Left Ventricular Remodeling Post Mitral Repair 03/17/26

Welcome to Cardiology Today – Recorded March 17, 2026. This episode summarizes 5 key cardiology studies on topics like preventive cardiology and sudden cardiac death. Key takeaway: Left Ventricular Remodeling Post Mitral Repair. Article Links: Article 1: Use of Coronary Artery Calcium Scoring in Individuals With Elevated Lipoprotein(a): A Multicohort Study. (Journal of the American College of Cardiology) Article 2: CRLF1 Secreted by Cardiac Fibroblasts Promotes Human Hypertrophic Cardiomyopathy. (Circulation) Article 3: Sports cardiology for the general cardiologist. (Heart (British Cardiac Society)) Article 4: Left Ventricular Reverse Remodeling after Mitral Transcatheter Edge-to-Edge Repair: Results from the EXPANDed Studies. (ESC heart failure) Article 5: Cardiac Biomarkers Response Under Angiotensin Receptor-Neprilysin Inhibitor: A Sub-Analysis of the Natrium-HF Study. (ESC heart failure) Full episode page: https://podcast.explainheart.com/podcast/left-ventricular-remodeling-post-mitral-repair-03-17-26/ Featured Articles Article 1: Use of Coronary Artery Calcium Scoring in Individuals With Elevated Lipoprotein(a): A Multicohort Study. Journal: Journal of the American College of Cardiology PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41837904 Summary: The current understanding in cardiology indicates that the utility of coronary artery calcium scoring for atherosclerotic cardiovascular disease risk assessment in individuals with elevated lipoprotein(a) is unclear. This ambiguity exists because lipoprotein(a) has a propensity toward non-calcified plaque, complicating traditional calcification-based risk evaluations. This uncertainty highlights a critical gap in refining cardiovascular disease prevention strategies for this specific patient population. Resolving this clinical question is essential for optimizing targeted interventions and improving patient outcomes. Article 2: CRLF1 Secreted by Cardiac Fibroblasts Promotes Human Hypertrophic Cardiomyopathy. Journal: Circulation PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41838796 Summary: R. L. F. 1 Secreted by Cardiac Fibroblasts Promotes Human Hypertrophic Cardiomyopathy. Nearly half of patients diagnosed with hypertrophic cardiomyopathy, the most common inherited cardiac disorder, currently lack identifiable sarcomere gene sequence variations. This significant proportion suggests the presence of undiscovered mechanisms driving the disease’s pathogenesis, highlighting its substantial genetic and clinical heterogeneity. A unified molecular basis underlying hypertrophic cardiomyopathy pathology remains to be fully elucidated. Identifying these unknown pathways is crucial for developing new diagnostic tools and targeted therapeutic interventions. Article 3: Sports cardiology for the general cardiologist. Journal: Heart (British Cardiac Society) PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41839544 Summary: Sports cardiology has emerged as a distinct subspecialty, integrating preventive cardiology with athlete care. While regular exercise provides substantial cardiovascular benefits, vigorous exertion can unmask latent disease and precipitate sudden cardiac death in predisposed individuals. This primer emphasizes the importance of early detection, comprehensive risk stratification, and tailored management strategies for athletes. Such events, though uncommon, carry profound societal impact and necessitate specialized attention from cardiologists. Article 4: Left Ventricular Reverse Remodeling after Mitral Transcatheter Edge-to-Edge Repair: Results from the EXPANDed Studies. Journal: ESC heart failure PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41839533 Summary: Left ventricular reverse remodeling stands as a critical therapeutic objective for contemporary heart failure management, aiming to reverse left ventricular dilation and dysfunction. Achieving this remodeling after mitral transcatheter edge-to-edge repair is a key indicator of successful treatment for both primary and secondary mitral regurgitation. Early indicators of left ventricular reverse remodeling within 30 days are crucial for assessing treatment efficacy and guiding patient prognosis. Understanding specific factors associated with this early remodeling can optimize future clinical decision-making and patient selection. Article 5: Cardiac Biomarkers Response Under Angiotensin Receptor-Neprilysin Inhibitor: A Sub-Analysis of the Natrium-HF Study. Journal: ESC heart failure PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41834516 Summary: F. Study. Natriuretic peptides are recognized as central biomarkers in the diagnostic and therapeutic management of heart failure. However, current understanding of their short-term dynamics during sacubitril/valsartan therapy and in response to acute volume changes remains incomplete. Characterizing these cardiac biomarker responses to angiotensin receptor-neprilysin inhibitor treatment is essential for optimizing patient monitoring and treatment adjustments. Elucidating these dynamics will enable clinicians to make more precise and timely therapeutic decisions for patients with heart failure with reduced ejection fraction. Transcript Today’s date is March 17, 2026. Welcome to Cardiology Today. Here are the latest research findings. Article number one. Use of Coronary Artery Calcium Scoring in Individuals With Elevated Lipoprotein(a): A Multicohort Study. The current understanding in cardiology indicates that the utility of coronary artery calcium scoring for atherosclerotic cardiovascular disease risk assessment in individuals with elevated lipoprotein(a) is unclear. This ambiguity exists because lipoprotein(a) has a propensity toward non-calcified plaque, complicating traditional calcification-based risk evaluations. This uncertainty highlights a critical gap in refining cardiovascular disease prevention strategies for this specific patient population. Resolving this clinical question is essential for optimizing targeted interventions and improving patient outcomes. Article number two. C. R. L. F. 1 Secreted by Cardiac Fibroblasts Promotes Human Hypertrophic Cardiomyopathy. Nearly half of patients diagnosed with hypertrophic cardiomyopathy, the most common inherited cardiac disorder, currently lack identifiable sarcomere gene sequence variations. This significant proportion suggests the presence of undiscovered mechanisms driving the disease’s pathogenesis, highlighting its substantial genetic and clinical heterogeneity. A unified molecular basis underlying hypertrophic cardiomyopathy pathology remains to be fully elucidated. Identifying these unknown pathways is crucial for developing new diagnostic tools and targeted therapeutic interventions. Article number three. Sports cardiology for the general cardiologist. Sports cardiology has emerged as a distinct subspecialty, integrating preventive cardiology with athlete care. While regular exercise provides substantial cardiovascular benefits, vigorous exertion can unmask latent disease and precipitate sudden cardiac death in predisposed individuals. This primer emphasizes the importance of early detection, comprehensive risk stratification, and tailored management strategies for athletes. Such events, though uncommon, carry profound societal impact and necessitate specialized attention from cardiologists. Article number four. Left Ventricular Reverse Remodeling after Mitral Transcatheter Edge-to-Edge Repair: Results from the EXPANDed Studies. Left ventricular reverse remodeling stands as a critical therapeutic objective for contemporary heart failure management, aiming to reverse left ventricular dilation and dysfunction. Achieving this remodeling after mitral transcatheter edge-to-edge repair is a key indicator of successful treatment for both primary and secondary mitral regurgitation. Early indicators of left ventricular reverse remodeling within 30 days are crucial for assessing treatment efficacy and guiding patient prognosis. Understanding specific factors associated with this early remodeling can optimize future clinical decision-making and patient selection. Article number five. Cardiac Biomarkers Response Under Angiotensin Receptor-Neprilysin Inhibitor: A Sub-Analysis of the Natrium-H. F. Study. Natriuretic peptides are recognized as central biomarkers in the diagnostic and therapeutic management of heart failure. However, current understanding of their short-term dynamics during sacubitril/valsartan therapy and in response to acute volume changes remains incomplete. Characterizing these cardiac biomarker responses to angiotensin receptor-neprilysin inhibitor treatment is essential for optimizing patient monitoring and treatment adjustments. Elucidating these dynamics will enable clinicians to make more precise and timely therapeutic decisions for patients with heart failure with reduced ejection fraction. Thank you for listening. Don’t forget to subscribe. Keywords preventive cardiology, sudden cardiac death, sports cardiology, left ventricular reverse remodeling, sarcomere gene variations, athlete care, heart failure, natriuretic peptides, left ventricular dysfunction, non-calcified plaque, atherosclerotic cardiovascular disease, coronary artery calcium score, mitral regurgitation, heart failure with reduced ejection fraction, mitral transcatheter edge-to-edge repair, risk stratification, cardiac fibroblasts, hypertrophic cardiomyopathy, risk assessment, sacubitril/valsartan, genetic defects, volume expansion, cardiac biomarkers, lipoprotein(a). About Concise summaries of cardiovascular research for professionals. Subscribe • Share • FollowThe post Left Ventricular Remodeling Post Mitral Repair 03/17/26 first appeared on Cardiology Today.